3/13
01:01 pm
kura
Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
3/12
04:07 pm
kura
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/8
08:34 am
kura
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
Medium
Report
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
3/6
08:55 am
kura
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.
Medium
Report
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.
3/6
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/5
10:17 pm
kura
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]
Medium
Report
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]
3/5
09:23 pm
kura
Kura Oncology Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Kura Oncology Q4 Earnings Call Highlights [Yahoo! Finance]
3/5
12:56 pm
kura
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/5
12:51 pm
kura
Kura Oncology, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Kura Oncology, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/5
06:57 am
kura
Kura Oncology: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Kura Oncology: Q4 Earnings Snapshot [Yahoo! Finance]
3/5
06:42 am
kura
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/5
06:31 am
kura
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
3/2
01:00 am
kura
Neutral
Report
2/28
05:57 am
kura
Kura Oncology (KURA) was upgraded by Zacks Research from "strong sell" to "hold".
Neutral
Report
Kura Oncology (KURA) was upgraded by Zacks Research from "strong sell" to "hold".
2/26
08:13 am
kura
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/26
07:30 am
kura
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
2/25
08:03 am
kura
Kura Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Kura Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
2/25
07:30 am
kura
Kura Oncology to Participate in Three Upcoming Investor Conferences
Low
Report
Kura Oncology to Participate in Three Upcoming Investor Conferences
2/22
02:02 am
kura
Low
Report
2/6
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/2
09:44 am
kura
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion [Yahoo! Finance]
Low
Report
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion [Yahoo! Finance]
1/24
06:45 am
kura
What Moved Markets This Week [Seeking Alpha]
Low
Report
What Moved Markets This Week [Seeking Alpha]
1/22
07:48 am
kura
Kura Oncology (NASDAQ:KURA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Kura Oncology (NASDAQ:KURA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/22
07:45 am
kura
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy [Seeking Alpha]
Medium
Report
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy [Seeking Alpha]
1/14
09:22 am
kura
Kura Oncology price target lowered to $20 from $25 at Leerink [Yahoo! Finance]
Low
Report
Kura Oncology price target lowered to $20 from $25 at Leerink [Yahoo! Finance]